, Tracking Stock Market Picks
Enter Symbol:
Novavax, Inc. (NVAX) [hlAlert]

up 190.50 %

Novavax, Inc. (NVAX) rated Buy with price target $7 by Merriman

Posted on: Thursday,  Nov 5, 2009  8:25 AM ET by Merriman

Merriman rated Buy Novavax, Inc. (NASDAQ: NVAX) on 11/05/2009, when the stock price was $4.00. Since
then, Novavax, Inc. has gained 190.50% as of 01/08/2016's recent price of $11.62.
If you would have followed this Merriman's recommendation on NVAX, you would have gained 190.5% of your investment in 2255 days.

Novavax, Inc. (Novavax) is a clinical-stage biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon preventive options for a range of infectious diseases. These vaccines leverage its virus-like particle (VLP) platform technology coupled with a disposable production technology. VLPs are genetically engineered three-dimensional nanostructures, which incorporate immunologically important lipids and recombinant proteins. Novavax?s VLPs resemble the virus but lack the genetic material to replicate the virus. Its production technology uses insect cells rather than chicken eggs or mammalian cells. The Company?s product targets include vaccines against the H5N1 and other subtypes of avian influenza with pandemic potential, human seasonal influenza, Varicella Zoster, which causes shingles, and respiratory syncytial virus (RSV). This RSV vaccine was announced on October 30, 2008.

Merriman provides advanced tools for acquiring such information. These tools integrate a combination of cycles, geocosmic signatures and trend analysis patterns in assisting the serious investor in their interpretation of the various financial markets and the general economy. In today's fast paced and seemingly chaotic marketplace, you need the edge that only a broader analysis of human activity can provide.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/5/2009 8:25 AM Buy
4.00 7.00
as of 12/31/2009
1 Week down  -19.86 %
1 Month down  -23.33 %
3 Months down  -42.50 %
1 YTD down  -42.50 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy